Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-amido-PEG3-C2-NH2 TFA (Cereblon Ligand-Linker Conjugates 3 (TFA)) is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG3-C2-NH2 TFA incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 40.00 | |
10 mg | In stock | $ 56.00 | |
25 mg | In stock | $ 81.00 | |
50 mg | In stock | $ 147.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 59.00 |
Description | Thalidomide-O-amido-PEG3-C2-NH2 TFA (Cereblon Ligand-Linker Conjugates 3 (TFA)) is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG3-C2-NH2 TFA incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. |
Synonyms | E3 ligase Ligand-Linker Conjugates 14 TFA, Cereblon Ligand-Linker Conjugates 3 (TFA) |
Molecular Weight | 620.54 |
Formula | C25H31F3N4O11 |
CAS No. | 1957236-21-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (80.58 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-amido-PEG3-C2-NH2 TFA 1957236-21-3 Others PROTAC E3 Ligase Ligand-Linker Conjugate Ligand for E3 Ligase E3 Ligase Ligand-Linker Conjugates Thalidomide O amido PEG3 C2 NH2 TFA Cereblon Ligand-Linker Conjugates 3 Thalidomide-O-amido-PEG-3-C2-NH2 TFA E3 ligase Ligand-Linker Conjugates 14 E3 ligase Ligand-Linker Conjugates 14 TFA inhibit Inhibitor ThalidomideOamidoPEG3C2NH2 TFA Cereblon Ligand-Linker Conjugates 3 (TFA) inhibitor